Retinol News and Research RSS Feed - Retinol News and Research

CWRU researchers find mechanism that enables LRAT enzyme to store vitamin A

CWRU researchers find mechanism that enables LRAT enzyme to store vitamin A

Researchers at Case Western Reserve University School of Medicine have uncovered the mechanism that enables the enzyme Lecithin: retinol acyltransferase (LRAT) to store vitamin A — a process that is indispensable for vision. [More]
Enzymatic activity essential for vision may provide target for drug transport

Enzymatic activity essential for vision may provide target for drug transport

Researchers at Case Western Reserve University School of Medicine have uncovered the mechanism that enables the enzyme Lecithin: retinol acyltransferase (LRAT) to store vitamin A--a process that is indispensable for vision. [More]
Researchers explore association between vitamin A and neonatal health

Researchers explore association between vitamin A and neonatal health

The impact vitamin A has on newborns is virtually unknown, but Penn State nutrition researchers have published two papers that may provide a framework for future investigations of the vitamin and neonatal health. [More]
ZO Skin Health reveals two new ZO Medical formulations to address hyperpigmentation

ZO Skin Health reveals two new ZO Medical formulations to address hyperpigmentation

ZO Skin Health, Inc. is excited to reveal two new products developed by Zein Obagi, MD to further enhance the ZO Skin Health Circle continuum of care – ZO Medical C-Bright 10% Vitamin C Serum and ZO Medical Brightalive Non-Retinol Skin Brightener. [More]
Researchers demonstrate potential of retinoic acid in preventing type 2 diabetes complications

Researchers demonstrate potential of retinoic acid in preventing type 2 diabetes complications

At a time when obesity, type 2 diabetes, and their complications are a veritable epidemic worldwide, researchers at the University of Montreal and CHUM Research Centre (CRCHUM) recently demonstrated the potential of retinoic acid (RA), a derivative of Vitamin A, in treating obesity and type 2 diabetes and preventing their cardiovascular complications. [More]
ZO Skin Health, Cellogique announce launch of ZO Medical products in Middle East

ZO Skin Health, Cellogique announce launch of ZO Medical products in Middle East

ZO Skin Health, Inc. and Cellogique Corporation are pleased to announce the launch of the ZO Medical product line to the Middle East region at The Dubai World Dermatology & Laser Conference & Exhibition – Dubai Derma, April 8-10, 2014. [More]
Researchers examine association between diabetes and obesity

Researchers examine association between diabetes and obesity

It's by now well established that obesity is a major risk factor for diabetes. But what exactly is it about extra body fat that leads to insulin resistance and blood glucose elevation, the hallmarks of diabetes? [More]
Vitamin A may play key role in combating TB, says study

Vitamin A may play key role in combating TB, says study

Tuberculosis is a major global problem, affecting 2 billion people worldwide and causing an estimated 2 million deaths annually. Western countries are once again tackling the disease, with recent outbreaks in Los Angeles and London. [More]
Murad launches Acne Spot Fast Fix and Acne Clearing Solution

Murad launches Acne Spot Fast Fix and Acne Clearing Solution

Murad, Inc., the skincare brand synonymous with high-performance, science-based products, announced today the addition of two new products, Acne Spot Fast Fix and Acne Clearing Solution, which are proven to enhance the effectiveness of the company's already award-winning Acne line. [More]
Alnylam initiates Phase II study with ALN-TTRsc for treatment of ATTR

Alnylam initiates Phase II study with ALN-TTRsc for treatment of ATTR

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a pilot Phase II study with ALN-TTRsc, a subcutaneously delivered RNAi therapeutic targeting the transthyretin gene in development for the treatment of TTR-mediated amyloidosis. [More]
UAB experts offer advice on how to slow aging, boost self-esteem

UAB experts offer advice on how to slow aging, boost self-esteem

For many men and women older than 30, the fun of birthdays fades with aging, but experts at the University of Alabama at Birmingham offer advice on how to slow aging and boost self-esteem. [More]
New strategy could lead researchers to rapidly detect nutritional deficiencies

New strategy could lead researchers to rapidly detect nutritional deficiencies

Johns Hopkins researchers have demonstrated that levels of certain proteins in the bloodstream may be used to estimate levels of essential vitamins and minerals without directly testing for each nutritional factor. [More]
Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive top-line results from its ongoing Phase I trial of ALN-TTRsc, a subcutaneously administered RNAi therapeutic targeting the transthyretin gene for the treatment of TTR-mediated amyloidosis. [More]
Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR). [More]
Excess vitamin A intake has calcification repercussions

Excess vitamin A intake has calcification repercussions

Excess dietary vitamin A intake is significantly associated with increased heart valve calcification, show results from an animal study. [More]
Genzyme, Alnylam partner to develop and commercialize RNAi therapeutics against ATTR

Genzyme, Alnylam partner to develop and commercialize RNAi therapeutics against ATTR

Alnylam Pharmaceuticals, Inc. and Genzyme, a Sanofi company, announced today that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin (TTR) for the treatment of transthyretin-mediated amyloidosis (ATTR) in Japan and other Asia-Pacific countries. [More]
Tomatoes every day may keep stroke at bay

Tomatoes every day may keep stroke at bay

Regular consumption of tomatoes and other lycopene-rich fruits and vegetables may help reduce a man’s risk for stroke, suggest study findings. [More]
Eating tomatoes associated with reduced risk of stroke

Eating tomatoes associated with reduced risk of stroke

Eating tomatoes and tomato-based foods is associated with a lower risk of stroke, according to new research published in the October 9, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Tomatoes are high in the antioxidant lycopene. [More]
Link between physical fitness and iron or vitamin status in adolescents

Link between physical fitness and iron or vitamin status in adolescents

Adolescence is an important time not only for growing but for acquiring healthy habits that will last a lifetime, such as choosing foods rich in vitamins and minerals, and adopting a regular exercise regimen. Unfortunately, several studies have shown that adolescents' intake of important nutrients, as well as their performance on standard physical fitness tests, has fallen in recent years. [More]
Positive results from Alnylam’s ALN-TTR02 Phase I trial on TTR-mediated amyloidosis

Positive results from Alnylam’s ALN-TTR02 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive clinical results from its Phase I trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis. [More]